Metropolis Healthcare Limited announced a significant board meeting outcome on February 04, 2026. The board approved the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. In a major decision, the company approved and recommended a bonus equity share issuance in the proportion of 3:1. This means shareholders will receive three fully paid-up equity shares of face value INR 2 for every one equity share of the same face value held on the record date. The record date for this bonus issue will be announced in due course. Furthermore, the board approved the sale and transfer of its External Quality Assessment Services Business (EQAS Division) to its wholly-owned subsidiary, Metropolis Quality Solutions Private Limited (MQSPL), via a slump sale. The consideration for this transaction is up to INR 1.25 crore, to be discharged in cash and/or equity shares of MQSPL. This move is intended to allow the EQAS Division to operate as a separate unit with dedicated resources for growth. The board meeting commenced at 11:15 a.m. (IST) and concluded at 03:40 p.m. (IST).
